This is a preview of subscription content, log in via an institution to check access.
Reference
BioTrends Research Group. Tecfidera's Patient Share at Three Months Postlaunch Surpasses That for Aubagio and Gilenya At the Same Stage of Their Launches. Media Release : 28 Aug 2013. Available from: URL: http://www.bio-trends.com
Rights and permissions
About this article
Cite this article
Patient share for Tecfidera growing. PharmacoEcon Outcomes News 686, 10 (2013). https://doi.org/10.1007/s40274-013-0695-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0695-9